Movement disorders refer to neurological diseases that affect the capability to control or generate movement. This disorder majorly affects the spinal cord, brain, and nerves of the human body, resulting in degenerative diseases of adult life, developmental disorders, cerebrovascular diseases, convulsive disorders, infectious diseases, trauma, neuro-genetic diseases, metabolic diseases, and brain tumors. Some of the movement disorders that have a high prevalence rate are Huntington’s disease, dystonia, Parkinson’s disease, essential tremor, and multiple system atrophy.
Perceive the Future Trends for Movement Disorders Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3111
The growing awareness among the patient population regarding neurological disorders and several treatments available for them is expected to drive the global movement disorder market in the coming years. In addition, the increasing research and development investments to develop new drugs is augmenting the growth of the market. However, the long approval time for new drugs and therapeutics and strict regulatory requirements are the key factors restricting the growth of the global movement disorder market.
In 2013, North America accounted for the largest share in the global movement disorder market and is estimated to remain in the leading position throughout the forecast period. The rapid growth of this region can be attributed to the growing awareness among the population regarding diagnosis, high prevalence of the disorder, and technological advancements. Europe holds the second-largest share in the global movement disorder market being the top research destination for neurological disorder diagnosis and treatment. Furthermore, Asia Pacific and Rest of the World are considered as the most potential markets for the global movement disorder market.
The global movement disorder market is extremely competitive owing to the presence of several players. The research study offers detailed profiles of the leading players to provide a clear understanding of the market. The product portfolio, financial overview, business policies, and recent developments in the market are also included in the report. Some of the prominent players mentioned in the research report are Hospira, Inc., Forest Laboratories, Pfizer, Inc., Baxter International, Inc., Torrent Pharma., Cardinal Health, Neuroptix Corporation, F. Hoffmann-La Roche AG, Boston Scientific Corporation, Merck Serono, Abbott Laboratories,Inc., Mylan Pharmaceuticals, and Medtronic, Inc.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453